The changing therapeutic landscape of castration-resistant prostate cancer

被引：0
|
作者：
Timothy A. Yap
Andrea Zivi
Aurelius Omlin
Johann S. de Bono
机构：
[1] Drug Development Unit,
[2] The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research,undefined
来源：
Nature Reviews Clinical Oncology | 2011年 / 8卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Treatment options for patients with castration-resistant prostate cancer are rapidly increasing, offering these patients hope of better quality of life and longer disease-free periods. This Review discusses the recent advances, the pitfalls and outlines a new treatment paradigm for the future.
引用
收藏
页码：597 / 610
页数：13
相关论文
共 50 条
  • [41] Corticotherapy in castration-resistant prostate cancer
    Lebdai, S.
    Branchereau, J.
    Robert, G.
    De La Tallie, A.
    Bouchaert, P.
    PROGRES EN UROLOGIE, 2013, 23 : S23 - S33
  • [42] Nonmetastatic Castration-Resistant Prostate Cancer
    Hong, Jun Hyuk
    Kim, Isaac Y.
    KOREAN JOURNAL OF UROLOGY, 2014, 55 (03) : 153 - 160
  • [43] Therapeutic opportunities for castration-resistant prostate cancer patients with bone metastases
    Zustovich, Fable
    Fabiani, Francesca
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2014, 91 (02) : 197 - 209
  • [44] Redox stress as a therapeutic Achilles heel in castration-resistant prostate cancer
    Troccoli, Clara I.
    Samaranayake, Govindi J.
    Huynh, Mai Q.
    Kage, Karen
    Kwon, Deukwoo
    Ban, Yuguang
    Chen, Xi S.
    Zarco, Enrique R.
    Jorda, Merce
    Burnstein, Kerry L.
    Rai, Priyamvada
    CANCER RESEARCH, 2017, 77
  • [45] Targeting TCTP as a New Therapeutic Strategy in Castration-resistant Prostate Cancer
    Baylot, Virginie
    Katsogiannou, Maria
    Andrieu, Claudia
    Taieb, David
    Acunzo, Julie
    Giusiano, Sophie
    Fazli, Ladan
    Gleave, Martin
    Garrido, Carmen
    Rocchi, Palma
    MOLECULAR THERAPY, 2012, 20 (12) : 2244 - 2256
  • [46] Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer
    Asangani, Irfan A.
    Dommeti, Vijaya L.
    Wang, Xiaoju
    Malik, Rohit
    Cieslik, Marcin
    Yang, Rendong
    Escara-Wilke, June
    Wilder-Romans, Kari
    Dhanireddy, Sudheer
    Engelke, Carl
    Iyer, Mathew K.
    Jing, Xiaojun
    Wu, Yi-Mi
    Cao, Xuhong
    Qin, Zhaohui S.
    Wang, Shaomeng
    Feng, Felix Y.
    Chinnaiyan, Arul M.
    NATURE, 2014, 510 (7504) : 278 - +
  • [47] LINE-1 as a therapeutic target for castration-resistant prostate cancer
    Houede, Nadine
    Piazza, Pier Vincenzo
    Pourquier, Philippe
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2018, 23 : 1292 - 1309
  • [48] Taxane resistance in castration-resistant prostate cancer: mechanisms and therapeutic strategies
    Brandon Bumbaca
    Wei Li
    Acta Pharmaceutica Sinica B, 2018, 8 (04) : 518 - 529
  • [49] BIOMARKERS FOR CHARACTERIZATION AND THERAPEUTIC ORIENTATION IN CASTRATION-RESISTANT PROSTATE CANCER (CRPC)
    Plata Bello, Ana
    Tamayo Jover, Marco Antonio
    Gutierrez Nicolas, Fernando
    Acosta Lopez, Silvia
    Concepcion Masip, Tomas
    Plata Bello, Julio
    ARCHIVOS ESPANOLES DE UROLOGIA, 2022, 75 (02): : 195 - 202
  • [50] Emerging therapeutic approaches in the management of metastatic castration-resistant prostate cancer
    E S Antonarakis
    A J Armstrong
    Prostate Cancer and Prostatic Diseases, 2011, 14 : 206 - 218
12345